Cronos Group Inc (CRON)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $1.20B
Last updated: Nov 17, 2026 at 4:37 PM ET
Cronos Group Inc (CRON) Stock Chart
Cronos Group (CRON) has a latest price of $3.19 on Nov 17, 2026, 18.4% below its 52-week high of $3.91. Its price rose 30.2% over the past 12 months. The month-end price rose 268.0% over the 10 years through Oct 2026, a compound annual rate of 13.9%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $21.64 in Feb 2019 and its lowest $0.90 in Oct 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CRON with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CRON.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 3.0%, and over 6 months it rose 22.2%. The month-end price rose 82.3% over the 3 years through Oct 2026, a compound annual rate of 22.2%.
| Period | Change |
|---|---|
| 1 month | -1.8% |
| 3 months | -3.0% |
| 6 months | +22.2% |
| 12 months | +30.2% |
| 12 months, with dividends | +30.2% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +82.3% | +22.2% |
| 5 years | -36.4% | -8.7% |
| 10 years | +268.0% | +13.9% |
Price by Year
Its best calendar year was 2017, when the price rose 600.9%, and its weakest was 2021, when it fell 43.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $3.30 | +25.5% |
| 2025 | $2.63 | +30.2% |
| 2024 | $2.02 | -3.3% |
| 2023 | $2.09 | -17.7% |
| 2022 | $2.54 | -35.2% |
| 2021 | $3.92 | -43.5% |
| 2020 | $6.94 | -9.5% |
| 2019 | $7.67 | -26.2% |
| 2018 | $10.39 | +34.4% |
| 2017 | $7.73 | +600.9% |
Trading Range
The price is 4.0% below its 50-day average of $3.32 and 9.9% above its 200-day average of $2.90.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $3.19 | |
| 52-week high | $3.91 | -18.4% |
| 52-week low | $2.28 | +39.9% |
| 50-day average | $3.32 | -4.0% |
| 200-day average | $2.90 | +9.9% |
Price Risk
Over 3 years, its largest fall from a peak was 46.4%.
| Measure | Value |
|---|---|
| 1-year beta | 0.38 |
| Largest fall, 1 year | -26.9% |
| Largest fall, 3 years | -46.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CRON
What is CRON's 1-year price change?
Cronos Group's price rose 30.2% over the past 12 months. With dividends included, the 12-month total return was 30.2%.
What is CRON's 5-year price change?
Cronos Group's month-end price fell 36.4% over the 5 years through Oct 2026, a compound annual decline of 8.7%. These figures leave out dividends.
What is CRON's 52-week high and low?
Cronos Group's 52-week high is $3.91 and its 52-week low is $2.28. Its latest price of $3.19 on Nov 17, 2026 is 18.4% below the high.
What is CRON's beta?
Cronos Group's 1-year beta against the S&P 500 is 0.38, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 26.9%.
Is the CRON chart free?
Yes. Advanced Charting for CRON is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CRON pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors